OncologyInformationService
Real World Databases
Evidence based Healthcare and Market Research
O.I.s) has become
TriNetX Oncology GmbH,
our new website is coming soon!
Why choose O.I.s)
Expert in Oncology
Expert in Healthcare Market Research
Warranty of Quality
International Team
Solutions
Decision Finder
Real World Data (TherapieMonitor)
Real World Evidence (Non-Interventional studies)
Evidence based Market Assessment & Dynamics (OncoRegioPanel)
Epidemiology, Healthcare Structure Research
References
Publications
Endorsements
Team
O.I.s) Team
Want to join us?
Current Projects
TherapieMonitor (RealWorldData)
TherapieMonitor Myelofibrose 2021
TherapieMonitor DLBCL 2L+ 2022
TherapieMonitor Multiples Myelom 1. Quartal 2023
TherapieMonitor Chronische Lymphatische Leukämie (CLL) 2021-2022
TherapyMonitor Leucemia Linfocítica Crónica (LLC) 2021-2022
OncoPanel
Barometer
Patient Reported Outcomes
COVID-19-Pandemie: Patientenbefragung 2020
Patienten-App MM: Patientenbefragung 2019
Are you interested to participate?
Imprint
Publikation
Treatment of Advanced Ovarian Cancer in Germany
A. du Bois, J. Pfisterer, L. Kellermann, in: Der Onkologe, Vol.8, Part. 11 2002, S. 2101-1215 -->
PDF